Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
Date: 12/15/2025 1. Introduction Tilray Brands, Inc. (NASDAQ: TLRY) is a diversified global lifestyle consumer packaged goods (CPG) company operating at the dynamic intersection of the cannabis, alcoholic beverage, and wellness industries. Headquartered in New York City, Tilray boasts a significant operational footprint across Canada, the United States, Europe, Australia, New Zealand, and Latin America, [...]
Tilray stock soared today after President Donald Trump signalled reclassification of cannabis as a Schedule III drug in the near-term. Here’s what that means for TLRY shares heading into 2026.
Monday’s tape felt like markets were pacing in the hallway before a doctor’s appointment: slightly red, slightly tense, and absolutely obsessed with the next data print. Oracle kept sliding on “more AI capex” anxiety, while Tesla ripped higher on Cathie Wood’s megaphone? plus a handful of single-stock soap operas stole the show.
As the trading day commenced on December 15, 2025, Wall Street opened with a complex tapestry of movements across its major indices. While the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite displayed a nuanced performance, market participants keenly observed several individual stocks making significant waves. The day's
A late-week mood swing around AI spending slammed tech and dragged the major indexes off record highs. Broadcom’s guidance nuance got punished, Oracle’s OpenAI data-center noise didn’t help, and suddenly “AI” felt less like a love story and more like a capex therapy session.
The financial markets experienced a week of significant upward momentum for several key players, culminating on December 13, 2025, as investors eagerly anticipated and then reacted to a confirmed Federal Reserve interest rate cut. This monetary policy shift, coupled with robust merger and acquisition (M&A) activity and strong corporate
Washington D.C. – December 12, 2025 – In a move sending seismic waves through the financial markets, President Donald Trump is reportedly poised to enact a landmark reclassification of marijuana, shifting it from a Schedule I to a Schedule III controlled substance under federal law. The news, which broke late on
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 40.8% in the afternoon session after reports suggested the Trump administration planned to ease federal restrictions on marijuana by reclassifying it as a less dangerous substance.
Broadcom shares were down more than 11% in Friday’s midday session after CEO Hock Tan’s $73 billion AI backlog order statement failed to impress Wall Street.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
